Syed N - Search Results

1

Inducible gene silencing in podocytes: a new tool for studying glomerular function.

Bugeon L, Danou A, Carpentier D, Langridge P, Syed N, Dallman MJ. Bugeon L, et al. Among authors: syed n. J Am Soc Nephrol. 2003 Mar;14(3):786-91. doi: 10.1097/01.asn.0000050222.86847.ea. J Am Soc Nephrol. 2003. PMID: 12595517

2

A fast and efficient method for transiently transfecting ES cells: application to the development of systems for conditional gene expression.

Bugeon L, Syed N, Dallman MJ. Bugeon L, et al. Among authors: syed n. Transgenic Res. 2000 Jun;9(3):229-32. doi: 10.1023/a:1008990510849. Transgenic Res. 2000. PMID: 11032372

3

Polo-like kinase Plk2 is an epigenetic determinant of chemosensitivity and clinical outcomes in ovarian cancer.

Syed N, Coley HM, Sehouli J, Koensgen D, Mustea A, Szlosarek P, McNeish I, Blagden SP, Schmid P, Lovell DP, Hatzimichael E, Crook T. Syed N, et al. Cancer Res. 2011 May 1;71(9):3317-27. doi: 10.1158/0008-5472.CAN-10-2048. Epub 2011 Mar 14. Cancer Res. 2011. PMID: 21402713 Free article.

4

p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis.

Bergamaschi D, Gasco M, Hiller L, Sullivan A, Syed N, Trigiante G, Yulug I, Merlano M, Numico G, Comino A, Attard M, Reelfs O, Gusterson B, Bell AK, Heath V, Tavassoli M, Farrell PJ, Smith P, Lu X, Crook T. Bergamaschi D, et al. Among authors: syed n. Cancer Cell. 2003 Apr;3(4):387-402. doi: 10.1016/s1535-6108(03)00079-5. Cancer Cell. 2003. PMID: 12726864 Free article.

5

Polymorphism in wild-type p53 modulates response to chemotherapy in vitro and in vivo.

Sullivan A, Syed N, Gasco M, Bergamaschi D, Trigiante G, Attard M, Hiller L, Farrell PJ, Smith P, Lu X, Crook T. Sullivan A, et al. Among authors: syed n. Oncogene. 2004 Apr 22;23(19):3328-37. doi: 10.1038/sj.onc.1207428. Oncogene. 2004. PMID: 15077186

6

Transcriptional silencing of Polo-like kinase 2 (SNK/PLK2) is a frequent event in B-cell malignancies.

Syed N, Smith P, Sullivan A, Spender LC, Dyer M, Karran L, O'Nions J, Allday M, Hoffmann I, Crawford D, Griffin B, Farrell PJ, Crook T. Syed N, et al. Blood. 2006 Jan 1;107(1):250-6. doi: 10.1182/blood-2005-03-1194. Epub 2005 Sep 13. Blood. 2006. PMID: 16160013 Free article.

7

DRAM, a p53-induced modulator of autophagy, is critical for apoptosis.

Crighton D, Wilkinson S, O'Prey J, Syed N, Smith P, Harrison PR, Gasco M, Garrone O, Crook T, Ryan KM. Crighton D, et al. Among authors: syed n. Cell. 2006 Jul 14;126(1):121-34. doi: 10.1016/j.cell.2006.05.034. Cell. 2006. PMID: 16839881 Free article.

8

Epigenetic inactivation implies a tumor suppressor function in hematologic malignancies for Polo-like kinase 2 but not Polo-like kinase 3.

Smith P, Syed N, Crook T. Smith P, et al. Among authors: syed n. Cell Cycle. 2006 Jun;5(12):1262-4. doi: 10.4161/cc.5.12.2813. Cell Cycle. 2006. PMID: 16868416

9

Epigenetic inactivation implies independent functions for insulin-like growth factor binding protein (IGFBP)-related protein 1 and the related IGFBPL1 in inhibiting breast cancer phenotypes.

Smith P, Nicholson LJ, Syed N, Payne A, Hiller L, Garrone O, Occelli M, Gasco M, Crook T. Smith P, et al. Among authors: syed n. Clin Cancer Res. 2007 Jul 15;13(14):4061-8. doi: 10.1158/1078-0432.CCR-06-3052. Clin Cancer Res. 2007. PMID: 17634530

10

Identification of CDK10 as an important determinant of resistance to endocrine therapy for breast cancer.

Iorns E, Turner NC, Elliott R, Syed N, Garrone O, Gasco M, Tutt AN, Crook T, Lord CJ, Ashworth A. Iorns E, et al. Among authors: syed n. Cancer Cell. 2008 Feb;13(2):91-104. doi: 10.1016/j.ccr.2008.01.001. Cancer Cell. 2008. PMID: 18242510 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

721 results

Search Page

Filters